Abstract
Faculty Opinions recommendation of Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have